Pfizer Q1 profit rises 61 percent to Rs 92 crore
New Delhi: Drug firm Pfizer reported 60.64% rise in standalone net profit to Rs 91.84 crore for the first quarter ended 30 June 2018-19.
It had posted a net profit of Rs 57.17 crore for the corresponding period of the previous fiscal, Pfizer Ltd said in a filing to BSE.
Standalone revenue from operations of the company stood at Rs 512.31 crore for the April-June quarter of the current fiscal.
It was Rs432.59 crore for the year-ago period.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd